157 related articles for article (PubMed ID: 15031575)
1. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
3. [Interventional therapy for lung cancer patients with superior vena cava syndrome].
Luo J; Chen B; Jiang S; Zhou SW
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):627-31. PubMed ID: 24314224
[TBL] [Abstract][Full Text] [Related]
4. [Accelerated hyperfractionation radiation therapy combined with chemotherapy for non-small cell lung cancer complicated with superior vena cava syndrome].
Ye M; Wang L; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):426-7. PubMed ID: 11810779
[TBL] [Abstract][Full Text] [Related]
5. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus.
Rowell NP; Gleeson FV
Cochrane Database Syst Rev; 2001; (4):CD001316. PubMed ID: 11687105
[TBL] [Abstract][Full Text] [Related]
6. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
7. [Stent implantation for the palliative therapy of upper inflow obstruction in bronchial carcinoma].
Wilhelm K; Schild H; Textor J; Mildenberger P; Strunk H; Terjung B; Lorenz J
Dtsch Med Wochenschr; 1995 Oct; 120(42):1419-25. PubMed ID: 7555670
[TBL] [Abstract][Full Text] [Related]
8. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
9. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
10. Superior vena cava syndrome revisited.
Chen YM; Yang S; Perng RP; Tsai CM
Jpn J Clin Oncol; 1995 Apr; 25(2):32-6. PubMed ID: 7745820
[TBL] [Abstract][Full Text] [Related]
11. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
15. Superior vena cava obstruction in small-cell lung cancer.
Chan RH; Dar AR; Yu E; Stitt LW; Whiston F; Truong P; Vincent MD; Kocha WI
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):513-20. PubMed ID: 9231674
[TBL] [Abstract][Full Text] [Related]
16. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
Hensing TA; Peterman AH; Schell MJ; Lee JH; Socinski MA
Cancer; 2003 Aug; 98(4):779-88. PubMed ID: 12910523
[TBL] [Abstract][Full Text] [Related]
17. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
18. Superior vena cava syndrome in small-cell lung cancer.
Urban T; Lebeau B; Chastang C; Leclerc P; Botto MJ; Sauvaget J
Arch Intern Med; 1993 Feb; 153(3):384-7. PubMed ID: 8381263
[TBL] [Abstract][Full Text] [Related]
19. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review.
Rowell NP; Gleeson FV
Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):338-51. PubMed ID: 12555872
[TBL] [Abstract][Full Text] [Related]
20. The difficulties of a randomized study in superior vena caval obstruction.
Wilson P; Bezjak A; Asch M; Barton R; Wong R; Levin W; Kane G; Kirkbride P
J Thorac Oncol; 2007 Jun; 2(6):514-9. PubMed ID: 17545846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
